However, a recent report found no significant difference in the JAK2 haplotypeGGCC_46/1 frequency between groups of MPN patients with different JAK2 V617F allele burdens [15], therefore this aspect remains to be further clarified. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.